Clofazimine‑induced premaculopathy in a vitiliginous patient

Kasturi, Nirupama; Srinivasan, Renuka

doi:10.4103/0976-500X.189685

Case ReportArchivesVol. 7 | Issue 3 | 2016 | pp. 149–151Open Access

Clofazimine‑induced premaculopathy in a vitiliginous patient

¹^*,
¹

¹Department of Ophthalmology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India Case Report.

Correspondence: Nirupama Kasturi
Department of Ophthalmology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India Case Report.
Email: kasturiniru@gmail.com

Published: Jan 1, 2016, Received: Apr 28, 2016, Accepted: Jul 15, 2016

DOI: https://doi.org/10.4103/0976-500X.189685
Article URL: https://www.jpharmacol.com/article/j-pharmacol-pharmacother-7-3-149
PDF URL: https://www.jpharmacol.com/article/j-pharmacol-pharmacother-7-3-149.pdf

Abstract

A 26‑year‑old male vitiliginous patient presented with decreased visual acuity because of a central scotoma in the left eye with no significant retinal changes on fundus examination. In this case report, a diagnosis of possible drug‑induced premaculopathy was made, and the drugs were withdrawn. On the follow‑up, after 3 months, the visual acuity in the left eye gradually improved. Early suspicion of drug‑induced maculopathy and withdrawal of the drug may prevent the progression of maculopathy.

Keywords

Subject

Readers Also Viewed

Original Research Article

Pharmacogenomics Meets Generative AI: Transforming Clinical Trial Design with Large Language Models

Annisa Fatharani, Ali Alsayegh

Jan 1, 2026

Review Article

Clinical Outcomes and Management of Post-varicocelectomy on Male Fertility: A Comprehensive Review

Mohammad Akbar Hossain

Jan 1, 2026

Original Research Article

Knowledge, Attitude, and Practice on Digital Eye Strain Among Healthcare Students at a Private University in Northern Peninsular Malaysia

Lim Chin Hung, Subramani Parasuraman, Sam Aaseer Thamby

Jan 1, 2026